Mitsui Chemicals, Inc. (4183)

Tokyo


	Symbol		Exchange		Currency
	4183		Tokyo		JPY	Delayed
	MITUY		OTC Markets		USD	Delayed
	4183		Frankfurt		EUR	Delayed

Currency in JPY

3,415.0

-1.0(-0.03%)

Delayed Data13:13:50

Fair Value

Day's Range

3,409.0

3,459.0

52 wk Range

3,167.0

4,836.0

4183 Income Statement

Featured here, the Income Statement (earnings report) for Mitsui Chemicals, Inc., showing the company's financial performance from operating and non operating activities such as revenue, expenses and income for the last 4 periods (either quarterly or annually).

Advanced Income Statement

Period Ending:

2015

31/03

2016

31/03

2017

31/03

2018

31/03

2019

31/03

2020

31/03

2021

31/03

2022

31/03

2023

31/03

2024

31/03

Total Revenues

1,338,987

1,211,725

1,612,688

1,879,547

1,749,743

Total Revenues Growth

-9.71%

-9.5%

+33.09%

+16.55%

-6.91%

Cost Of Revenues

1,041,840

917,883

1,233,948

1,498,054

1,378,946

Gross Profit

297,147

293,842

378,740

381,493

370,797

Gross Profit Growth

-6.06%

-1.11%

+28.89%

+0.73%

-2.8%

Gross Profit Margin %

22.19%

24.25%

23.49%

20.3%

21.19%

Other Operating Expenses, Total

228,218

212,715

245,977

290,765

284,901

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	+2.38%	-6.79%	+15.64%	+18.21%	-2.02%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	36,368	33,802	38,124	42,954	44,695
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	191,850	168,245	195,593	233,508	223,538
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-1,830	-690	-1,614	-525

Operating Income

68,929

81,127

132,763

90,728

85,896

Operating Income Growth

-26.22%

+17.7%

+63.65%

-31.66%

-5.33%

EBIT Margin %

5.15%

6.7%

8.23%

4.83%

4.91%

Net Interest Expenses

-674

-2,659

-1,626

-1,068

-1,554

Net Interest Expenses Growth

-0.3%

-294.51%

+38.85%

+34.32%

-45.51%

Interest Expense, Total

-5,501

-4,811

-4,083

-6,078

-7,866

Interest And Investment Income

4,827

2,152

2,457

5,010

6,312

Other Non Operating Expenses, Total

-2,738

7,735

29,103

19,099

16,143

EBT, Excl. Unusual Items

65,517

86,203

160,240

108,759

100,485

Gain (Loss) On Sale Of Assets

-3,779

-3,392

-5,050

-7,136

-6,167

Other Unusual Items, Total

18,659

-8,565

-16,184

-7,469

-24,156

EBT, Incl. Unusual Items

68,460

74,243

141,274

117,278

73,331

EBT, Incl. Unusual Items Growth

-34.98%

+8.45%

+90.29%

-16.99%

-37.47%

EBT, Incl. Unusual Items Margin

5.11%

6.13%

8.76%

6.24%

4.19%

Income Tax Expense

22,171

10,024

22,723

27,140

19,556

Net Income to Company

46,289

64,219

118,551

90,138

53,775

Minority Interest

-8,345

-6,346

-8,561

-7,202

-3,776

Net Income

37,944

57,873

109,990

82,936

49,999

Net Income Growth

-50.15%

+52.52%

+90.05%

-24.6%

-39.71%

Net Income Margin %

2.83%

4.78%

6.82%

4.41%

2.86%

Preferred Dividend and Other Adjustments

-

-

-

-

-

Net Income to Common Excl. Extra Items

37,944

57,873

109,990

82,936

49,999

Basic EPS - Continuing Operations

194.94

298

565.45

431.17

262.99

Basic EPS - Continuing Operations Growth

-49.45%

+52.87%

+89.75%

-23.75%

-39.01%

Diluted EPS - Continuing Operations

194.94

298

565.45

431.17

262.99

Diluted EPS - Continuing Operations Growth

-49.45%

+52.87%

+89.75%

-23.75%

-39.01%

Basic Weighted Average Shares Outstanding

194.65

194.2

194.52

192.35

190.12

Diluted Weighted Average Shares Outstanding

194.65

194.2

194.52

192.35

190.12

Dividend Per Share

100

100

115

120

140

Dividend Per Share Growth

0%

0%

+15%

+4.35%

+16.67%

EBITDA

121,035

157,748

216,985

182,808

181,145

EBITDA Growth

-15.32%

+30.33%

+37.55%

-15.75%

-0.91%

EBITDA Margin %

9.04%

13.02%

13.45%

9.73%

10.35%

EBIT